About Oui Therapeutics
Oui Therapeutics is a Healthcare company based in New Haven (United States) founded in 2018 by Brian Keenaghan, Leng Lee, and Seth Feuerstein. Prescription digital therapeutics for suicide prevention are developed. Oui Therapeutics has raised $26 million across 6 funding rounds from investors including HHS, First Round Capital and CVS Health Ventures. The company has 9 employees. Its chief executive, as recorded, is Seth Feuerstein. Oui Therapeutics offers products and services including Digital Therapeutic for Suicide. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its legal entity is Oui Therapeutics, Inc. Its competitors include Better Therapeutics, SilverCloud and Waypoint Health; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2018 and based in New Haven, United States, the company operates in the digital therapeutics sector focused on mental health. Prescription-based digital tools are developed to support suicide prevention efforts. Clinical trials are conducted to assess treatment efficacy, with collaboration involving experts in digital therapy and suicide prevention. Solutions are designed for individuals at risk, emphasizing evidence-based digital interventions.
- Headquarters New Haven, United States
- Employees 9
- Founders Brian Keenaghan, Leng Lee, Seth Feuerstein
- SectorsHealthcare
- Email••••••••
- Website ouitherapeutics.com
- Social LinkedIn
- Legal Name Oui Therapeutics, Inc.
- Total Equity Funding$26M (USD)
in 6 rounds
- Latest Funding Round$440.09K (USD), Grant
Jun 2024
- InvestorsHHS
& 2 more
- Employee Count9
Products & Services of Oui Therapeutics
Oui Therapeutics offers a comprehensive portfolio of products and services, including Digital Therapeutic for Suicide.
Prescription-based digital tool to prevent suicide through expert-guided interventions.
Funding Insights of Oui Therapeutics
Oui Therapeutics has successfully raised a total of $26M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $440.09 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26M
- Total Rounds 6
- Last Round Grant — $440,092
- First Round $3.48M
(Jul 2020)
- Investors Count 3
All 6 funding rounds of Oui Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $440,092 | Grant | – | – | |
| Sep 2023 | $375,273 | Grant | – | – | |
| Sep 2022 | $659,522 | Grant | – | – | |
| Aug 2022 | $26M | Series B | – | – | |
| Feb 2021 | $1.77M | Grant | – | – | |
| Jul 2020 | $3.48M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Oui Therapeutics
Oui Therapeutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, First Round Capital and CVS Health Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused seed and early-stage VC firm | firstround.com | San Francisco, United States | ||
Venture capital investment for the healthcare industry | cvshealthventures.com | Woonsocket, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Oui Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oui Therapeutics
7 people are tracked at Oui Therapeutics (4 in leadership, 3 in team); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Brian Keenaghan | Co-Founder & VP of Operations | Leadership |
Leng Lee | Co-Founder & CPO | Leadership |
Seth Feuerstein | Co-Founder & CEO | Leadership |
Patricia Simon | VP, Clinical | Leadership |
Mfundi Makama | Project Manager | Team |
Melissa Nagrabski | Operation Coordinator | Team |
Adriana Guzman | Clinical Research Manager | Team |
Complete people profiles for Oui Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oui Therapeutics
3 dated milestones of Oui Therapeutics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Oui Therapeutics is founded.
- Funding First funding round of $3.5M.
- Funding Latest funding round, Grant, of $440K.
Competitors of Oui Therapeutics
Oui Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Better Therapeutics, SilverCloud and Waypoint Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bettertx.com | 2015 | San Francisco, United States | $6.75M | 54 | AI-based cardiac therapy planning software is developed for professionals. | |
| silvercloudhealth.com | 2011 | Boston, United States | $26.06M | 12 | Mental health programs are delivered through a cloud-based platform. | |
| waypointhealth.com | 2007 | Madison, United States | $855,000 | Web-based self-help programs that teach cognitive behavior therapy (CBT) skills |
Detailed competitors of Oui Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Oui Therapeutics (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oui Therapeutics
Oui Therapeutics was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Oui Therapeutics is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Seth Feuerstein is the CEO of Oui Therapeutics, as recorded in our data. They have also founded this company.
Oui Therapeutics is a funded company, having raised a total of $26M across 6 funding rounds to date. The company's 1st funding round was a Grant of $3.48M, raised on Jul 2020.
Oui Therapeutics has 9 employees.
Founded in 2018 and based in New Haven, United States, the company operates in the digital therapeutics sector focused on mental health. Prescription-based digital tools are developed to support suicide prevention efforts. Clinical trials are conducted to assess treatment efficacy, with collaboration involving experts in digital therapy and suicide prevention. Solutions are designed for individuals at risk, emphasizing evidence-based digital interventions.
Oui Therapeutics's top competitors include SilverCloud, Better Therapeutics and Waypoint Health.
Oui Therapeutics offers Digital Therapeutic for Suicide.
Oui Therapeutics has 3 investors. Key investors include HHS, First Round Capital, and CVS Health Ventures.
Oui Therapeutics operates through Oui Therapeutics, Inc..